Component

ISCU knockdown in human cells

2 recorded relationships. Experimental role, claim status and evidence remain attached to each record.

How nutrients influence it

Every nutrient with a recorded effect on this component, credited to the nutrient that acted rather than the chapter that recorded it. Open a nutrient to see the findings and the conditions they were measured under.

How nutrients reach it in more than one step

Chains of two or more recorded steps that end here, grouped by the nutrient they start from. Each step is a separate finding, so a chain is a route a mechanism could take, not proof that it does.

Tracing routes…

What it does

Every recorded relationship this component is part of, grouped by its role. Plain wording comes first; the technical statement follows.

Recorded relationships

What it acts on

  1. ISCU depletion attenuated iron-chelation-induced ISR activation.

    Experimental context and source evidence
    access_level
    selected_indexed_full_text_passages
    dose
    Unresolved; not inferred from another panel
    duration
    72-hour siRNA reported; exact supplementary exposure schedule unresolved
    endpoint
    ATF4/ISR immunoblot readout
    evidence_cache
    artifacts/discovery-research/round2-sources/iscu-counterevidence-search.json; SHA256 91e6dd454b1fdecf0cf4d29d2579bf1eba148109e446059f91ea966f8bf0de21
    experimental_model
    Human cultured cells; precise supplementary-panel cell assignment unresolved
    exposure
    Iron chelation; panel-specific agent and concentration unresolved
    limitations
    Selected primary Results and figure legends accessed through indexed text. Supplements were not independently inspected. These results constrain a hypothesis; they do not test SLC25A39 loss or establish its bypass. Exact iron sensor and transporter substrate remain unresolved.
    organism
    Human
    primary_locator
    https://pmc.ncbi.nlm.nih.gov/articles/PMC10329284/ Results discussing Figure S6B/C
    primary_references
    https://doi.org/10.1016/j.molcel.2023.05.031

    Requirements for iron-triggered DELE1 signaling · lines 48–59

    Primary study 10.1016/j.molcel.2023.05.031; targeted counterevidence curation, 2026-09-20. · supports · Human cultured cells; precise supplementary-panel cell assignment unresolved · source_derived_draft · unverified_draft

    ISCU depletion attenuated iron-chelation-induced ISR activation. primary_references: https://doi.org/10.1016/j.molcel.2023.05.031 primary_locator: https://pmc.ncbi.nlm.nih.gov/articles/PMC10329284/ Results discussing Figure S6B/C evidence_cache: artifacts/discovery-research/round2-sources/iscu-counterevidence-search.json; SHA256 91e6dd454b1fdecf0cf4d29d2579bf1eba148109e446059f91ea966f8bf0de21 access_level: selected_indexed_full_text_passages organism: Human experimental_model: Human cultured cells; precise supplementary-panel cell assignment unresolved duration: 72-hour siRNA reported; exact supplementary exposure schedule unresolved exposure: Iron chelation; panel-specific agent and concentration unresolved dose: Unresolved; not inferred from another panel endpoint: ATF4/ISR immunoblot readout limitations: Selected primary Results and figure legends accessed through indexed text. Supplements were not independently inspected. These results constrain a hypothesis; they do not test SLC25A39 loss or establish its bypass. Exact iron sensor and transporter substrate remain unresolved.
    Complete structured claim and evidence
  2. ISCU depletion attenuated DELE1 stabilization during iron chelation.

    Experimental context and source evidence
    access_level
    selected_indexed_full_text_passages
    dose
    Unresolved; not inferred from another panel
    duration
    72-hour siRNA reported; exact supplementary exposure schedule unresolved
    endpoint
    DELE1 protein stability immunoblot readout
    evidence_cache
    artifacts/discovery-research/round2-sources/iscu-counterevidence-search.json; SHA256 91e6dd454b1fdecf0cf4d29d2579bf1eba148109e446059f91ea966f8bf0de21
    experimental_model
    Human cultured cells; precise supplementary-panel cell assignment unresolved
    exposure
    Iron chelation; panel-specific agent and concentration unresolved
    limitations
    Selected primary Results and figure legends accessed through indexed text. Supplements were not independently inspected. These results constrain a hypothesis; they do not test SLC25A39 loss or establish its bypass. Exact iron sensor and transporter substrate remain unresolved.
    organism
    Human
    primary_locator
    https://pmc.ncbi.nlm.nih.gov/articles/PMC10329284/ Results discussing Figure S6B/C
    primary_references
    https://doi.org/10.1016/j.molcel.2023.05.031

    Requirements for iron-triggered DELE1 signaling · lines 62–73

    Primary study 10.1016/j.molcel.2023.05.031; targeted counterevidence curation, 2026-09-20. · supports · Human cultured cells; precise supplementary-panel cell assignment unresolved · source_derived_draft · unverified_draft

    ISCU depletion attenuated DELE1 stabilization during iron chelation. primary_references: https://doi.org/10.1016/j.molcel.2023.05.031 primary_locator: https://pmc.ncbi.nlm.nih.gov/articles/PMC10329284/ Results discussing Figure S6B/C evidence_cache: artifacts/discovery-research/round2-sources/iscu-counterevidence-search.json; SHA256 91e6dd454b1fdecf0cf4d29d2579bf1eba148109e446059f91ea966f8bf0de21 access_level: selected_indexed_full_text_passages organism: Human experimental_model: Human cultured cells; precise supplementary-panel cell assignment unresolved duration: 72-hour siRNA reported; exact supplementary exposure schedule unresolved exposure: Iron chelation; panel-specific agent and concentration unresolved dose: Unresolved; not inferred from another panel endpoint: DELE1 protein stability immunoblot readout limitations: Selected primary Results and figure legends accessed through indexed text. Supplements were not independently inspected. These results constrain a hypothesis; they do not test SLC25A39 loss or establish its bypass. Exact iron sensor and transporter substrate remain unresolved.
    Complete structured claim and evidence

In the sources

Preserved passages that mention this component, quoted exactly. Open one to read it in context.

    This is a research prototype built from draft material. It is not medical advice, and its statements still await verification against the original studies.

    Evidence, AI assistance and curation standards